vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and SAUL CENTERS, INC. (BFS). Click either name above to swap in a different company.
SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -19.9%, a 28.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 10.6%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 6.2%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
ABCL vs BFS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $75.1M |
| Net Profit | $-8.9M | $6.5M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 65.4% |
| Net Margin | -19.9% | 8.7% |
| Revenue YoY | 788.4% | 10.6% |
| Net Profit YoY | 73.9% | -19.6% |
| EPS (diluted) | $-0.03 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $75.1M | ||
| Q3 25 | $9.0M | $72.0M | ||
| Q2 25 | $17.1M | $70.8M | ||
| Q1 25 | $4.2M | $71.9M | ||
| Q4 24 | $5.0M | $67.9M | ||
| Q3 24 | $6.5M | $67.3M | ||
| Q2 24 | $7.3M | $66.9M | ||
| Q1 24 | $10.0M | $66.7M |
| Q4 25 | $-8.9M | $6.5M | ||
| Q3 25 | $-57.1M | $10.5M | ||
| Q2 25 | $-34.7M | $10.7M | ||
| Q1 25 | $-45.6M | $9.8M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | $-51.1M | $14.5M | ||
| Q2 24 | $-36.9M | $14.4M | ||
| Q1 24 | $-40.6M | $13.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 73.6% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.8% |
| Q4 25 | -63.7% | 65.4% | ||
| Q3 25 | -851.8% | 69.1% | ||
| Q2 25 | -290.2% | 68.7% | ||
| Q1 25 | -1479.6% | 66.5% | ||
| Q4 24 | — | 82.9% | ||
| Q3 24 | -1439.4% | 72.8% | ||
| Q2 24 | -1276.2% | 75.0% | ||
| Q1 24 | -551.5% | 72.4% |
| Q4 25 | -19.9% | 8.7% | ||
| Q3 25 | -637.8% | 14.6% | ||
| Q2 25 | -203.3% | 15.1% | ||
| Q1 25 | -1077.2% | 13.6% | ||
| Q4 24 | — | 11.9% | ||
| Q3 24 | -785.4% | 21.5% | ||
| Q2 24 | -504.3% | 21.6% | ||
| Q1 24 | -408.0% | 20.4% |
| Q4 25 | $-0.03 | $0.15 | ||
| Q3 25 | $-0.19 | $0.32 | ||
| Q2 25 | $-0.12 | $0.33 | ||
| Q1 25 | $-0.15 | $0.29 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-0.17 | $0.48 | ||
| Q2 24 | $-0.13 | $0.48 | ||
| Q1 24 | $-0.14 | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $8.7M |
| Total DebtLower is stronger | — | $468.4M |
| Stockholders' EquityBook value | $966.9M | $307.8M |
| Total Assets | $1.4B | $2.2B |
| Debt / EquityLower = less leverage | — | 1.52× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $8.7M | ||
| Q3 25 | $83.2M | $11.8M | ||
| Q2 25 | $92.4M | $5.3M | ||
| Q1 25 | $159.3M | $6.5M | ||
| Q4 24 | $156.3M | $10.3M | ||
| Q3 24 | $126.6M | $7.2M | ||
| Q2 24 | $148.3M | $6.9M | ||
| Q1 24 | $123.6M | $7.1M |
| Q4 25 | — | $468.4M | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $455.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $966.9M | $307.8M | ||
| Q3 25 | $964.0M | $316.6M | ||
| Q2 25 | $1.0B | $322.4M | ||
| Q1 25 | $1.0B | $328.4M | ||
| Q4 24 | $1.1B | $335.8M | ||
| Q3 24 | $1.1B | $341.8M | ||
| Q2 24 | $1.1B | $345.7M | ||
| Q1 24 | $1.1B | $347.1M |
| Q4 25 | $1.4B | $2.2B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.3B | $2.1B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.4B | $2.1B | ||
| Q2 24 | $1.4B | $2.1B | ||
| Q1 24 | $1.5B | $2.0B |
| Q4 25 | — | 1.52× | ||
| Q3 25 | — | 5.02× | ||
| Q2 25 | — | 4.85× | ||
| Q1 25 | — | 4.70× | ||
| Q4 24 | — | 1.36× | ||
| Q3 24 | — | 4.37× | ||
| Q2 24 | — | 4.17× | ||
| Q1 24 | — | 4.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $99.8M |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | 15.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $99.8M | ||
| Q3 25 | $-52.6M | $20.6M | ||
| Q2 25 | $-32.4M | $26.6M | ||
| Q1 25 | $-11.6M | $30.4M | ||
| Q4 24 | $-108.6M | $121.2M | ||
| Q3 24 | $-28.9M | $26.5M | ||
| Q2 24 | $-30.0M | $32.1M | ||
| Q1 24 | $-41.7M | $33.8M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | — | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | — | ||
| Q3 24 | $-47.4M | $-28.3M | ||
| Q2 24 | $-50.1M | $-12.5M | ||
| Q1 24 | $-65.8M | $-11.7M |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | — | ||
| Q2 25 | -267.9% | — | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | — | ||
| Q3 24 | -728.4% | -42.1% | ||
| Q2 24 | -683.8% | -18.7% | ||
| Q1 24 | -661.5% | -17.6% |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | — | ||
| Q2 25 | 78.2% | — | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | — | ||
| Q3 24 | 284.6% | 81.5% | ||
| Q2 24 | 274.6% | 66.7% | ||
| Q1 24 | 242.5% | 68.3% |
| Q4 25 | — | 15.35× | ||
| Q3 25 | — | 1.97× | ||
| Q2 25 | — | 2.48× | ||
| Q1 25 | — | 3.10× | ||
| Q4 24 | — | 14.98× | ||
| Q3 24 | — | 1.83× | ||
| Q2 24 | — | 2.22× | ||
| Q1 24 | — | 2.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
